Clinical Trial Update: Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mepolizumab for chronic obstructive pulmonary disease with eosinophilic bronchitis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: McMaster University | Conditions: Chronic Obstructive Pulmonary Diseases, Chronic Airways Limitation | Phase 3 | Status: COMPLETED | Results posted: 2025-09-24